§ BIOTECHNOLOGY
USD · Biotechnology

DAWN

DAY ONE BIOPHARMACEUTICALS I
USDSector · BiotechnologyBeta · 0.65
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
0 increased/new, 1 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B2.17EPS (TTM)-1.04
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
BlackRock, Inc.7.0M0.0%−20%
FIL Ltd4.1M0.1%n/a
Kryger Capital LLC3.9M5.9%n/a
DEERFIELD MANAGEMENT COMPANY, L.P.3.7M0.9%±0%
VANGUARD CAPITAL MANAGEMENT LLC3.4Mn/an/a
JPMORGAN CHASE & CO3.1Mn/a+7101%
◇ AC INTELLIGENCE

Top institutional owners for DAWN as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER6.3% · 0 holders
OTHER49.5% · 139 holders
DEALER / BANK13.8% · 23 holders
PASSIVE / INDEX9.7% · 8 holders
QUALITY / COMPOUNDER9.3% · 15 holders
TACTICAL / MACRO7.0% · 5 holders
SYSTEMATIC / QUANT3.2% · 10 holders
INCOME / DEFENSIVE1.1% · 11 holders
GROWTH / MOMENTUM0.1% · 1 holder
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for DAWN in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention DAWN yet.